Metraipolis › archive › dc_b473bfbf4881

Impact of Chemotherapy Dose Intensity on Pathological Complete Response in Pembrolizumab-Treated Early Triple-Negative Breast Cancer: A Real-World Multicenter… — Europe PMC PMID:41228347

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41228347
DOI
10.3390/cancers17213554
License (as archived)
solo-consultazione
Archived
2026-11-08T20:24:55.957Z
SHA-256 of the archived text
1ce0c0ae79e4723c50178fc6dd0015c7a4fd2d0b402914b24e6bd843b2877a40
Stable URL of this page
https://metraipolis.com/documento/dc_b473bfbf4881

How to cite

Impact of Chemotherapy Dose Intensity on Pathological Complete Response in Pembrolizumab-Treated Early Triple-Negative Breast Cancer: A Real-World Multicenter… — Europe PMC PMID:41228347 — Europe PMC (en), https://europepmc.org/article/MED/41228347 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b473bfbf4881 (Metraipolis archive dc_b473bfbf4881, sha256 1ce0c0ae79e4723c50178fc6dd0015c7a4fd2d0b402914b24e6bd843b2877a40)
BibTeX
@misc{dcb473bfbf4881,
  title = {Impact of Chemotherapy Dose Intensity on Pathological Complete Response in Pembrolizumab-Treated Early Triple-Negative Breast Cancer: A Real-World Multicenter… — Europe PMC PMID:41228347},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41228347},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b473bfbf4881; sha256 1ce0c0ae79e4723c50178fc6dd0015c7a4fd2d0b402914b24e6bd843b2877a40},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41228347. Agents can read the archived copy with the MCP tool read_document.